Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Ipca Labs falls 15% as US regulator bans drug import

      Ipca Labs falls 15% as US regulator bans drug import

      Ruby Khatun Khatun17 Jun 2017 11:24 AM IST
      New Delhi: Ipca Laboratories shares tanked over 15 per cent on Friday as almost all drugs manufactured by the company at its facilities at Pithampur,...
      No decision yet on ways to raise up to Rs 5,000 crore: Fortis on IHH bid News

      No decision yet on ways to raise up to Rs 5,000 crore: Fortis on IHH bid News

      Ruby Khatun Khatun17 Jun 2017 11:22 AM IST
      New Delhi: Fortis Healthcare, which has already got shareholders nod to raise up to Rs 5,000 crore, said its board has not taken any decision over the...
      Government of India bans Fixed dose combination of Glucosamine, Ibuprofen

      Government of India bans Fixed dose combination of Glucosamine, Ibuprofen

      Ruby Khatun Khatun17 Jun 2017 9:36 AM IST
      Department of Health and Family Welfare of Ministry of Health and Family Welfare, Government of India has banned fixed dose combinations of...
      Teva Pharmaceuticals Recalls Paliperidone Extended Release Tablets 3mg Due To Dissolution Test Failure

      Teva Pharmaceuticals Recalls Paliperidone Extended Release Tablets 3mg Due To Dissolution Test Failure

      Ruby Khatun Khatun17 Jun 2017 9:25 AM IST
      Teva Pharmaceuticals USA, Inc. (Teva) initiated a voluntary recall to retail-level on 05/31/2017 for one lot of Paliperidone Extended-Release Tablets,...
      UK will pay for Roche breast cancer drug at center of price row

      UK will pay for Roche breast cancer drug at center of price row

      Ruby Khatun Khatun17 Jun 2017 9:25 AM IST
      London: A Roche breast cancer drug at the center of a prolonged pricing row in Britain will now be paid for routinely, following a discount deal...
      Apple to turn iPhone into hub of medical info

      Apple to turn iPhone into hub of medical info

      Ruby Khatun Khatun16 Jun 2017 9:07 PM IST
      San Francisco: According to a media report Apple is working to turn iPhone into a hub of all your medical information which will reduce the burden of...
      Zydus Cadila gets USFDA nod for anti-viral drug

      Zydus Cadila gets USFDA nod for anti-viral drug

      Ruby Khatun Khatun16 Jun 2017 9:07 PM IST
      New Delhi: Drug firm Zydus Cadila said the US health regulator has given its nod to market Acylovir drug for injection used as an anti-viral chiefly...
      Ranbaxy in another medicine recall in South Africa

      Ranbaxy in another medicine recall in South Africa

      Ruby Khatun Khatun16 Jun 2017 9:07 PM IST
      Johannesburg: Indian drug-maker Ranbaxy Pharmaceuticals announced recalling batches of its deworming medication Wormstop Suspension in South Africa,...
      Lupin receives FDA approval for generic Roxicodone Tablets

      Lupin receives FDA approval for generic Roxicodone Tablets

      Ruby Khatun Khatun16 Jun 2017 10:35 AM IST
      Mumbai: Pharma Major Lupin Limited (Lupin) announced that it has received final approval for its Oxycodone Hydrochloride Tablets USP, 5 mg, 10 mg, 15...
      Dr Reddys recalls 3.25 lakh cartons Cipla made acne drug from US

      Dr Reddy's recalls 3.25 lakh cartons Cipla made acne drug from US

      Ruby Khatun Khatun16 Jun 2017 10:31 AM IST
      New Delhi: Drug firm Dr Reddy's Laboratories Inc is recalling over 3.25 lakh cartons of Zenatane (isotretinoin) capsules, used for treatment of severe...
      Glenmark gets USFDA tentative nod for Saxagliptin tablets

      Glenmark gets USFDA tentative nod for Saxagliptin tablets

      Ruby Khatun Khatun16 Jun 2017 9:31 AM IST
      New Delhi: Drug firm Glenmark has received tentative nod from the US health regulator for Saxagliptin tablets."Glenmark Pharmaceuticals Inc, USA...
      Cognizant to acquire HCSC subsidiary TMG Health

      Cognizant to acquire HCSC subsidiary TMG Health

      Ruby Khatun Khatun15 Jun 2017 12:17 PM IST
      TEANECK, N.J.: Cognizant announced it has entered into a definitive agreement to purchase Health Care Service Corporation's (HCSC) subsidiary TMG...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok